Study of an SGLT2 pill for sleep apnea in overweight adults
Part of Brain & nervous system, Lungs & breathing clinical trials.
This study tests whether taking an SGLT2 inhibitor pill (bexagliflozin) can improve obstructive sleep apnea and related body measurements. It focuses on people who are overweight or obese and have confirmed obstructive sleep apnea.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign consent, follow study instructions, and stay available for the whole study
- Your body weight is in the overweight/obese range (BMI 25 to 40)
- You have confirmed obstructive sleep apnea (sleep test shows AHI or REI 15+ per hour)
- You are not using sleep-inducing medicines like benzodiazepines or opioid pain medicines
- You are able to have MRI scans (not too claustrophobic and no metal implants that block MRI)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medication (IBI362) to see if it can improve sleep apnea in people with obesity. You might qualify if you have moderate to severe sleep apnea and a BMI of 28 or higher, whether or not you currently use a CPAP machine.
This study tests an investigational injection for obstructive sleep apnea (a condition where breathing stops during sleep) in people who are overweight or have obesity. The treatment may help reduce sleep apnea events and improve sleep quality.
This study tests whether a new injectable medicine called NNC0487-0111 helps people with excess weight and moderate-to-severe obstructive sleep apnea (a condition where breathing stops repeatedly during sleep) lose weight and improve their sleep apnea—without needing a CPAP machine. The goal is to see if better weight loss can reduce sleep apnea symptoms.
This study checks how stopping CPAP treatment for a short time affects glucose levels in people with sleep apnea who do not have diabetes. It may help find out if sleep apnea is linked to blood sugar problems.
This trial tests an injectable medication (HRS9531) to see if it helps people with both obstructive sleep apnea and obesity. It compares the drug to a placebo (no active medicine) to check safety and effectiveness.
This study tests an investigational medicine given as an injection to help people with obstructive sleep apnea and a high body mass index (BMI). It may reduce breathing pauses during sleep and support weight loss, all while you continue using your CPAP machine.
Hear when a new Sleep Apnea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.